Advanced School In Benefits and Risks In Life Sciences (Advanced School In Benefits and Risks In Life Sciences)
Owner/Developer: Mario Negri Institute
01 July 2018
The IRCCS - lstituto di Ricerche Farmacologiche Mario Negri has established a competition for admission to four positions in the "Advanced School in Benefits and Risks in Life Sciences through Computational Methods" for the years 2018-2021.
The course, aimed at training researchers in the field of computational toxicology, involves integration of the studenťs own theoretical preparation with practical experience that the student will acquire at the Institute in the development and use of in silico models and, in general, non-testing methods. The course will be run at the Institute in Milan and will last three years. At the end of the course, students who have passed a final exam will be issued an "Attestation of Attendance". The training activity carried out does not in any way imply the establishment of a work relationship under any title at the Institute.
Hands-on training, Lecture
Students may apply for participation in the competition for admission to the Course, without limitation of citizenship, and must, upon submission of the application, possess at least one of the following degrees:
a five-year / senior degree in scientific disciplines
a degree "vecchio ordinamento" (ex D.M. 509/99) in scientific disciplines
a master's degree (2nd level degree in D.M. 509/99 and D. M. 270/04) in scientific disciplines
a degree obtained at foreign universities and recognized as eligible
Continuing Professional Development
Full coverage (a dedicated course)
Fant du det du lette etter?Ja, jeg fant det! Nei, jeg fant det ikke!
Takk for din tilbakemelding! Vær oppmerksom på at vi ikke kan kontakte deg hvis ikke du oppgir din epostadresse.
Hva lette du etter?
Gi oss gjerne en tilbakemelding slik at vi kan forbedre informasjonen på siden. På forhånd takk for hjelpen! Vennligst skriv inn din epostadresse hvis du vil ha et svar.Kontakt oss gjerne på e-post hvis du har spørsmål.